Andrew Farb, MD
US Food and Drug Administration
Columbia,
MD
USA
Biographical Sketch: Andrew Farb, M.D. is the Chief Medical Officer in the Office of Cardiovascular Devices at FDA’s Center for Devices and Radiological Health. He has multiple publications on coronary atherosclerosis and mechanisms of thrombosis, coronary artery interventions, and structural heart disease. He joined the FDA in 2004, where he has concentrated on clinical study development for interventional cardiology, structural heart, and peripheral vascular devices. He is the Co-Leader of CDRH’s Early Feasibility Study Program. In addition to his position at FDA, Andrew provides cardiovascular pathology consultations and engages in direct patient care as an attending physician in clinical cardiology..
Papers: